Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Birmingham, Alabama
  • +111 more
Oct 25, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Gilbert, Arizona
  • +16 more
Sep 13, 2022

Breast Cancer Trial in United States (T-DM1)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +13 more
Aug 25, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Breast Cancer Trial in Worldwide (LY3484356)

Recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Aug 17, 2022

Advanced Cancer, Metastatic Cancer, Breast Cancer Trial in United Kingdom, United States (ART4215, Talazoparib, Niraparib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Orlando, Florida
  • +6 more
Aug 16, 2022

Breast Cancer Trial in United States (ARV-471 in combination with Everolimus)

Not yet recruiting
  • Breast Cancer
  • ARV-471 in combination with Everolimus
  • San Diego, California
  • +4 more
Aug 12, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +3 more
  • Chandler, Arizona
  • +226 more
Aug 11, 2022

Tumors, Breast Tumors, Breast Tumors, Triple-Negative Trial in Korea, Republic of, Spain, United States (CX-2009, CX-072)

Active, not recruiting
  • Neoplasms
  • +4 more
  • La Jolla, California
  • +41 more
Aug 5, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Breast Cancer Trial in United States (Letrozole, Tamoxifen, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Stamford, Connecticut
  • +10 more
Jul 15, 2022

Inherited Cancer Syndrome, Prostate Cancer, Colorectal Cancer Trial in Nashville (Correlative Studies (Survey), Correlative

Not yet recruiting
  • Inherited Cancer Syndrome
  • +4 more
  • Correlative Studies (Survey)
  • +4 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jul 5, 2022

Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

Active, not recruiting
  • Breast Neoplasms
  • +7 more
  • Goodyear, Arizona
  • +38 more
Jun 29, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in United States (trastuzumab-emtansine, Trastuzumab SC, Paclitaxel)

Recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Stamford, Connecticut
  • +16 more
Jun 20, 2022

Collecting and Storing Tissue Samples From or Without Breast

Recruiting
  • Breast Cancer
  • biologic sample preservation procedure
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 17, 2022

Quality of Life in Female Breast Cancer Survivors and Their

Completed
  • Breast Cancer
  • +5 more
  • cognitive assessment
  • +2 more
  • Monterey, California
  • +103 more
Jun 8, 2022

A Retrospective Breast Reconstruction Study

Completed
  • Breast Cancer
  • SimpliDerm HADM
  • +4 more
  • Montgomery, Alabama
  • +4 more
Jun 6, 2022

Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +7 more
May 15, 2022

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)

Recruiting
  • Breast Cancer
  • +3 more
  • San Francisco, California
  • +8 more
May 25, 2022

Sarcoma, Melanoma, Lung Cancer Trial in United States (PRT1419)

Recruiting
  • Sarcoma
  • +6 more
  • Denver, Colorado
  • +6 more
May 26, 2022

Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))

Active, not recruiting
Has Results
  • Breast Cancer
  • Aurora, Colorado
  • +132 more
Apr 26, 2022

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022